Prevalence, Predictors, and Management of Acute Chest Syndrome in Patients with Sickle Cell Disease at Muhimbili National Hospital, Tanzania: A Retrospective Study. [PDF]
Masoud SA +16 more
europepmc +1 more source
Factors associated with longitudinal hydroxyurea adherence trajectories among individuals with sickle cell disease in Texas Medicaid: A group-based trajectory modeling study. [PDF]
Okoye BI, Okoye G, Barner JC.
europepmc +1 more source
Seroprotection after measles vaccination in children with sickle cell anemia receiving hydroxyurea. [PDF]
Power-Hays A +6 more
europepmc +1 more source
Understanding the role of superoxide in mediating the teratogenicity of hydroxyurea
Hydroxyurea is a teratogen; treatment of dams during organogenesis causes various malformations. Administration of a free radical scavenger ameliorates the embryotoxicity of hydroxyurea, suggesting that oxidative stress mediates this toxicity.
Larouche, Geneviève.
core
A national spatial prioritisation framework for the targeted expansion of essential sickle cell disease services across health-facility catchments in Uganda. [PDF]
Paasi G +7 more
europepmc +1 more source
L-Glutamine for Pediatric Sickle Cell Disease: Pharmacology, Mechanism of Action, Safety and Efficacy. [PDF]
Panosyan EH.
europepmc +1 more source
A non-IMiD multi-target degrader reactivates fetal hemoglobin. [PDF]
Liu J +40 more
europepmc +1 more source
Cyanosis and extensive erythroid dysplasia in a young adult with hemoglobin M-Hyde Park (Akita). [PDF]
Toorani Z +4 more
europepmc +1 more source
Hydroxyurea (hydroxycarbamide) in haemoglobin SC disease: Moving from therapeutic hesitation to evidence-guided care. [PDF]
Setayesh T.
europepmc +1 more source
Hydroxyurea treatment is not significantly associated with reduced spermatogonial numbers in patients with sickle cell disease. [PDF]
De Beer E +3 more
europepmc +1 more source

